TABLE 1.
Participant clinical and laboratory characteristicsa
| Characteristic | Total | TB case | Non-TB case |
|---|---|---|---|
| n = 131 | n = 64 | n = 67 | |
| Gender, n (%) | |||
| Female | 59 (45) | 28 (44) | 31 (46) |
| Male | 72 (55) | 36 (56) | 36 (54) |
| Age, median (IQR) | 36 (31–46) | 35 (28–49) | 37 (33–46) |
| HIV status, n (%) | |||
| Negative | 10 (8) | 10 (16) | 0 (0) |
| Positive | 121 (92) | 54 (84) | 67 (100) |
| CD4+ T-cell count, median (IQR)b | 115 (37–319) | 89 (40–227) | 257 (100–551) |
| Cough present, n (%) | 98 (75) | 56 (88) | 42 (63) |
| Any TB symptom present, n (%)c | 128 (97) | 64 (100) | 64 (96) |
| Urine LF-LAM positive, n (%)d | 22 (17) | 22 (34) | 0 (0) |
| OSA positive (Cq < 32), n (%) | 27 (21) | 25 (39) | 2 (3) |
| OSA positive (Cq < 38), n (%) | 57 (44) | 42 (65) | 15 (22) |
| Xpert Ultra Ct, median (IQR)e | 16.5 (15.9–20.8) |
a
TB case: reference sputum TB positive (Xpert Ultra and/or culture); Non-TB case: no positive sputum results.
b
HIV-positive participants only; data available for n = 105.
c
TB symptoms queried: cough, weight loss, fevers/chills, loss of appetite, fatigue.
d
LF-LAM, lateral flow lipoarabinomannan test.
e
Cycle threshold (Ct) values available for 60/62 positive Xpert Ultra results.